glp 1 agonist 종류 학술특집] 최근 당뇨치료의 세계적 이슈, '인크레틴 제제'1 < 학술연구 < 학술·학회 < 기사본문 GLP-1 Agonists: A Comprehensive Overview

Ozempic and Wegovy are GLP-1 receptor agonists

Naltrexone-bupropion carries black-box warnings regarding neuropsychiatric effects and seizure risk, particularly in patients with prior seizures or psychiatric conditions

The GLP-1 receptor is expressed in the pancreas, gastrointestinal tract, kidney, heart, and brain [11]

Further details regarding the characteristics of the included studies can be found in Tables 12

Resmetirom works independently of weight loss and is particularly well-suited for lean patients, who represent 10% to 20% of the MASH population and often lack procedural options due to body mass index requirements